Covidien launches new catheter in U.S. and EU; Meridian gets FDA OK for strep throat Dx;

 @FierceMedDev: BioFire Diagnostics pulls in $25M in new funding for accelerated product development. Release | Follow @FierceMedDev

 @MarkHFierce: The iPhone 5 could accelerate the migration of medical devices to Bluetooth, eWeek reports. More | Follow @MarkHFierce

 @DamianFierce: Medtronic is looking to pair its pump technology with the next generation of Alzheimer's drugs. Report | Follow @DamianFierce

> Covidien ($COV) has launched the Viance crossing catheter and Enteer re-entry system, designed to treat chronic total occlusions endovascularly, in the U.S. and EU. More

> Meridian Bioscience ($VIVO) got FDA approval for its new molecular diagnostic test for Group A strep throat. Item

> Sequenom ($SQNM) raised $130 million through the sale of senior notes, money the company will use to market its MaterniT21 Plus pre-natal test. Story

> AtriCure has treated its first patient with its new atrial fibrillation device, the first part of an FDA-approved pilot study. Release

> Codman & Shutleff is touting positive data for its vascular reconstruction device, a self-expanding stent designed to treat patients with wide neck saccular aneurysms. Article

> Fortune has a blow-by-blow account of Synthes' illegal tests of its bone cement. News

> Malaysia's Medical Device Authority is reforming its regulatory policies, seeking public comment on proposed new rules for devicemakers there. Report

> DFine has launched its Star tumor ablation system in the U.S. Release

> Canadian cancer diagnostics company Mitomics says it has a bright future, despite recent job cuts. More

Biotech News

 @FierceBiotech: Bedside blood infection test being developed for sepsis. Item | Follow @FierceBiotech

 @JohnCFierce: Interesting: J&J setting up 4 deal teams around the globe - Boston. California. China and London. Via ReutersReport | Follow @JohnCFierce

 @RyanMFierce: Fierce 15 arrives tomorrow. Here are some details on what to expect: More | Follow @RyanMFierce

> Medtronic dangles Alzheimer's delivery tech to frustrated pharmas. Story

> Software mogul commits $104M to CureVac's cancer vax work. More

Pharma News

 @FiercePharma: WSJ's story on the Chinese drug-price cuts: Report | Follow @FiercePharma

> Analysts eye generic threat as Vivus rolls out Qsymia. Article

> Merck yanks European app for Erbitux in lung cancer. Story

> Costly cancer drugs get the Chinese price-cutting treatment. More

Pharma Manufacturing News

> Gelatin prices look to rise steeply. Story

> Boehringer Ingelheim closing 1 of 3 U.S. API plants. More

> India says it will meet EU's API quality deadline. Report

Biotech Research News

> Mayo Clinic spies enzyme that destroys brain-clogging Alzheimer's protein. More

> Drug combo packs punch fighting rare form of melanoma in mice. Story

> UMass sensor array 'smelled' metastatic cancer cells in preclinical study. Article

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.